News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Quick Read Trump Media abandoned its bitcoin treasury after a $190 million paper loss, with Rumble gaining 4% as investors rotated to crypto-free alt-media. MSTR sits on a $10 billion bitcoin paper loss and faces forced-selling risk as the corporate crypto treasury model loses …
Sharemaestro market context Price below Trend Line 52 weeks -53.7%In August 2026, GE Appliances, a Haier company, announced it had chosen U.S.-manufactured Texas Instruments microcontrollers, Wi‑Fi solutions, and analog components to supply around one-third of the semiconductors for its new Louisville laundry plant, nearly doubling its chip spending with TI. This long-term supply …
Shares of Northrop Grumman Corp. (NOC) fell by 2.67% on Monday, closing at $570.20. This underperformance occurred during a generally poor trading session, with both the S&P 500 Index and Dow Jones Industrial Average also declining. The stock is currently 26.33% below its 52-week …
Fulcrum Therapeutics, which previously cut 85% of its workforce after discontinuing its sickle cell disease program, is undergoing a reverse merger with North Carolina-based Slate Medicines. The merger is anticipated to finalize in the fourth quarter of the year. Fulcrum is currently located at …
By Karen Roman Fulcrum Therapeutics, Inc. (Nasdaq: FULC) said it is merging with Slate Medicines, Inc. to advance next-generation therapeutics to treat migraine and other headache disorders, with the combining company operating as Slate Medicines, Inc. and trading on Nasdaq under the ticker "SLTE." …
MKS CEO John Tseng-Chung Lee recently sold 10,000 shares of the company's stock for over $3 million, reducing his direct ownership by 6.91%. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. Despite the insider sale, analysts maintain a "Moderate Buy" rating …
A $75 million class action settlement has been reached with Northrop Grumman for alleged soil and groundwater contamination in Canoga Park and Winnetka, which supposedly decreased property values. Current and former owners of single-family homes or townhomes within designated sub-areas may be eligible to …
Glancy Prongay Wolke & Rotter LLP is urging shareholders of Alarum Technologies, Ltd. (ALAR) who suffered losses to contact them regarding a securities fraud lawsuit. The lawsuit stems from allegations that Alarum's subsidiary, NetNut, engaged in illegal activities by linking customer internet devices without …
Fulcrum Therapeutics Inc (NASDAQ:FULC) shares rose after announcing a definitive agreement to merge with Slate Medicines Inc in an all-stock transaction. The combined company, to be named Slate Medicines, will focus on advancing migraine therapeutics and secured an oversubscribed private placement of $245 million …
Fulcrum Therapeutics is merging with Slate Medicines, a privately held migraine-focused biotech company, in an all-stock transaction valued at $245 million, expected to close in Q4 2026. The combined entity will be renamed Slate Medicines and trade under the Nasdaq ticker SLTE. This deal …
Fulcrum Therapeutics announced an all-stock merger with privately held Slate Medicines following the discontinuation of its lead drug candidate. The combined company will operate as Slate Medicines, trading under the ticker "SLTE" on Nasdaq, and gains access to Slate's experimental migraine drug, SLTE-1009. The …
Texas Instruments has launched what it claims is the first commercially available CAN XL transceiver, the TCAN6062. This new offering supports high-bandwidth data rates up to 20 Mb/s and payloads up to 2,048 bytes per frame, designed specifically for the demanding needs of industrial …
Alberta Investment Management Corp (AIMCo) has acquired a new position in Spectrum Brands Holdings Inc. (NYSE:SPB), purchasing 540,556 shares valued at approximately $46.4 million. Several other institutional investors also increased their holdings in the company. Spectrum Brands recently reported strong quarterly earnings, beating consensus …
Fulcrum Therapeutics (NASDAQ: FULC) and Slate Medicines have announced an all-stock merger to create a combined company focused on migraine therapeutics, to be renamed Slate Medicines, Inc. and trade under the symbol SLTE. The merger includes a $245 million private placement for Slate, and …
Fulcrum Therapeutics has announced a stock-for-stock merger with Slate Medicines, supported by a $245 million private placement. Upon closing, current Slate holders will own a majority stake, while Fulcrum plans a significant cash dividend to its stockholders, a reverse stock split, and a name …
Fulcrum Therapeutics and Slate Medicines have announced a definitive merger agreement to combine in an all-stock transaction. The combined entity, to be named Slate Medicines, Inc., will focus on advancing Slate's pipeline of next-generation migraine therapeutics, including SLTE-1009, a clinical-stage subcutaneous anti-PACAP/VIP monoclonal antibody. …
Old West Investment Management LLC has acquired a new position in Veeco Instruments Inc. (NASDAQ:VECO), purchasing 62,423 shares valued at approximately $4.73 million. This comes as Veeco Instruments exceeded quarterly earnings and revenue expectations, reporting $0.33 EPS and $193.48 million in revenue. Despite positive …
Simplicity Wealth LLC has acquired a new position of 1,816 shares in Northrop Grumman Corporation, valued at approximately $925,000, during the second quarter. Other institutional investors also increased their holdings in the company. Northrop Grumman recently exceeded quarterly earnings expectations, reported a 5.1% increase …
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Headache drug specialist Slate Medicines said Monday it will combine with struggling biotechnology firm Fulcrum Therapeutics, two months after the latter announced …
Old West Investment Management LLC recently acquired 8,790 shares of MKS Inc. (NASDAQ:MKSI), valued at approximately $3.91 million. This purchase contributes to the 99.79% institutional ownership of MKS, which has demonstrated strong financial performance, beating Q2 earnings and revenue estimates. Analysts currently rate MKSI …
For Immediate Release Chicago, IL – August 17, 2026 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and …
Mirum Pharmaceuticals (MIRM) reported wider net losses in Q2 and H1 2026, yet its share price has seen significant gains, up 28.91% year-to-date and 50.93% over one year. The company is currently trading at approximately $100, which analysts suggest is 30.2% undervalued with a …
5 Revealing Analyst Questions From Rumble's Q2 Earnings Call Rumble's results for the second quarter were met with a positive market reaction, driven by the company's transformative move into AI infrastructure following the acquisition of Northern Data. Management attributed the surge in revenue primarily …
Search by ticker symbol or company name and select a result to open its chart. The US only control limits results to active US-listed stocks and ETFs.
Showing active US-listed stocks and ETFs only.